切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Smoothened - Insulin Receptors - cannabinoid receptor - Calcium-Activated Potassium (KCa) Channels

11件产品中的 1-10

页面
每页
清除全部
  1. Insulin (human) recombinant expressed in yeast
    B7407 Insulin (human) recombinant expressed in yeast
    中文名: 胰岛素
    Target: Insulin Receptors
    Summary: 内源性胰岛素受体激动剂
      ≥58.1 mg/mL
      insoluble in H2O
  2. GW842166X
    B1428 GW842166X
    Target: cannabinoid receptor
    Summary: 大麻素受体激动剂
      Soluble in DMSO
  3. Dequalinium Chloride
    B2191 Dequalinium Chloride
    中文名: 地喹氯铵
    Target: PKC|Calcium-Activated Potassium (KCa) Channels
    Summary: PKC抑制剂
      insoluble in DMSO
      insoluble in H2O
  4. LDE225 (NVP-LDE225,Erismodegib)
    B2266 LDE225 (NVP-LDE225,Erismodegib)
     1 Citation
    中文名: 索尼德吉
    Target: Smoothened
    Summary: Smoothened抑制剂
      ≥24.3 mg/mL
      insoluble in H2O
  5. PF-04449913
    B3283 PF-04449913
    中文名: 格拉吉布
    Target: Smoothened
    Summary: Smoothened拮抗剂
      ≥20.15 mg/mL
      insoluble in H2O
  6. Cyclopamine
    A8340 Cyclopamine
     1 Citation
    中文名: 环巴胺
    Target: Smoothened
    Summary: Hedgehog (Hh)信号抑制剂
      ≥6.86 mg/mL
      insoluble in H2O
  7. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O
  8. CP-724714
    A2412 CP-724714
    Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1R
    Summary: 有效的HER2选择性抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  9. TRAM-34
    A1888 TRAM-34
    Target: Calcium-Activated Potassium (KCa) Channels
    Summary: KCa3.1阻断剂
      ≥17.25 mg/mL
      insoluble in H2O
  10. LDE225 Diphosphate
    A3543 LDE225 Diphosphate
    Target: Smoothened
    Summary: Smo拮抗剂
      ≥27.85 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页